Inhibition of Endothelin-1-Mediated Contraction of Hepatic Stellate Cells by FXR Ligand
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Activation of hepatic stellate cells (HSCs) plays an important role in the development of cirrhosis through the increased production of collagen and the enhanced contractile response to vasoactive mediators such as endothelin-1 (ET-1). The farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily that is highly expressed in liver, kidneys, adrenals, and intestine. FXR is also expressed in HSCs and activation of FXR in HSCs is associated with significant decreases in collagen production. However, little is known about the roles of FXR in the regulation of contraction of HSCs. We report in this study that treatment of quiescent HSCs with GW4064, a synthetic FXR agonist, significantly inhibited the HSC transdifferentiation, which was associated with an inhibition of the upregulation of ET-1 expression. These GW4064-treated cells also showed reduced contractile response to ET-1 in comparison to HSCs without GW4064 treatment. We have further shown that GW4064 treatment inhibited the ET-1-mediated contraction in fully activated HSCs. To elucidate the potential mechanism we showed that GW4064 inhibited ET-1-mediated activation of Rho/ROCK pathway in activated HSCs. Our studies unveiled a new mechanism that might contribute to the anti-cirrhotic effects of FXR ligands.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Further consequences of FXR activation include the downregulation of ECM expression in HSCs and fibrogenesis via an increased mrR-29a promoter activity [66], and the inhibition of endothelin-1 (ET-1) [67], which would enhance pro-fibrogenic gene expression in HSCs.[68]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,634
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274 · cited 1×
“FXR has the typical nuclear receptor structure and can be activated by structurally different ligands, including several primary and secondary bile acid (BA) species conjugated to either taurine or glycine [10].”
BackgroundPellicciari, R., Fiorucci, S., Camaioni, E., Clerici, C., Costantino, G., Maloney, P. R., Morelli, A., Parks, D. J., & Willson, T. M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025529g · Cited by 743 · cited 1×
“In addition to BAs, a number of synthetic FXR agonists have been developed, among which GW4064 is one of the most potent FXR agonists [11,12].”
BackgroundAngiotensin II induces contraction and proliferation of human hepatic stellate cells
Bataller, R., Ginès, P., Nicolás, J. M., Görbig, M. N., Garcia–Ramallo, E., Gasull, X., Bosch, J., Arroyo, V., & Rodés, J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70368-4 · Cited by 490 · cited 2×
“A number of vasoactive molecules can trigger contractile response in HSCs with endothelin-1 being the most potent constrictor [4,5,6].”
BackgroundBile Acid Regulation of Gene Expression: Roles of Nuclear Hormone Receptors
Chiang, J. Y. L. (2002) · Endocrine Reviews · doi:10.1210/er.2000-0035 · Cited by 484 · cited 3×
“the synthesis and transport of BAs [13,14,15].”
Fiorucci, S., Antonelli, E., Rizzo, G., Renga, B., Mencarelli, A., Riccardi, L., Orlandi, S., Pellicciari, R., & Morelli, A. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.08.001 · Cited by 472 · cited 1×
“production [16].”
Perisinusoidal stellate cells of the liver: important roles in retinol metabolism and fibrosis
Blomhoff, R., & Wake, K. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.3.2001786 · Cited by 388 · cited 2×
“It has been well established that activation of HSCs plays a key role in the development of cirrhosis [1].”
BackgroundRockey, D. C., & Weisiger, R. A. (1996) · Hepatology · doi:10.1002/hep.510240137 · Cited by 385 · cited 2×
“A number of vasoactive molecules can trigger contractile response in HSCs with endothelin-1 being the most potent constrictor [4,5,6].”
BackgroundCasini, A., Ceni, E., Salzano, R., Biondi, P., Parola, M., Galli, A., Foschi, M., Caligiuri, A., Pinzani, M., & Surrenti, C. (1997) · Hepatology · doi:10.1002/hep.510250218 · Cited by 302
Adipogenic Transcriptional Regulation of Hepatic Stellate Cells
She, H., Xiong, S., Hazra, S., & Tsukamoto, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410078200 · Cited by 299 · cited 2×
“These include retinoid X receptor, PPARs, pregnane-X-receptor, and FXR [7,8,9,23].”
Background
Cited by
Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update
Elpek, G. Ö. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7260 · Cited by 382
Verbeke, L., Farre, R., Trebicka, J., Komuta, M., Roskams, T., Klein, S., Elst, I. V., Windmolders, P., Vanuytsel, T., Nevens, F., et al. (2014) · Hepatology · doi:10.1002/hep.26939 · Cited by 258
“For this purpose, we performed an in vitro collagen lattice contraction assay, in which we could confirm only a marginal loss of contractility at the higher concentrations of INT-747, as described by Li et al.(28) However, on the molecular level, this did not coincide with increased SHP expression nor with decreased e…”
BackgroundMethodUpdate on FXR Biology: Promising Therapeutic Target?
Han, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19072069 · Cited by 185
“Abbreviations ABC ATP-binding cassette ALD alcoholic liver disease AMPK AMP-activated protein kinase Bas bile acids BDL bile duct ligation BSEP bile salt export pump CAR constitutive androstane receptor CCl4 carbon tetrachloride C/EBP CCAAT-enhancer-binding protein CYP7A1 cholesterol 7α-hydroxylase DILI drug-induced l…”
BackgroundInfluentialSchwabl, P., Hambruch, E., Seeland, B. A., Hayden, H., Wagner, M., Garnys, L., Strobel, B., Schubert, T.-L., Riedl, F., Mitteregger, D., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.005 · Cited by 178
Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?
Khanam, A., Saleeb, P. G., & Kottilil, S. (2021) · Cells · doi:10.3390/cells10051097 · Cited by 131
Metadata
- Authors
- Li, J., Kuruba, R., Wilson, A., Gao, X., Zhang, Y., & Li, S.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Li, Song
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-11-11
- Volume
- 5
- Issue
- 11
- Pages
- e13955
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2978707
- OpenAlex
- W2008996867
- Cited by
- 66
- References
- 31
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2022: 10 · 2021: 9 · 2020: 3 · 2019: 6 · 2018: 10 · 2017: 3 · 2016: 3 · 2015: 5 · 2014: 5 · 2013: 3 · 2012: 4
- FWCI
- 1.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- D-Scholarship@Pitt (University of Pittsburgh) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL091828, R01HL091828)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- hepatic stellate cells, endothelin-1, farnesoid X receptor, FXR agonists, GW4064, cell contraction, liver cirrhosis, Rho/ROCK signaling, collagen synthesis
- MeSH terms
- Receptor, Farnesoid X-Activated, Animals, Cells, Cultured, Gene Expression Regulation, Isoxazoles, Male, Microfilament Proteins, Phosphorylation, Blotting, Western, Signal Transduction, Rats, Sprague-Dawley, Receptors, Cytoplasmic and Nuclear, Endothelin-1, Reverse Transcriptase Polymerase Chain Reaction, Cell Shape, Rats, Cell Transdifferentiation, rho-Associated Kinases, Hepatic Stellate Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.